MEDICLIN Aktiengesellschaft (FRA:MED)

Germany flag Germany · Delayed Price · Currency is EUR
4.020
+0.020 (0.50%)
At close: Jan 30, 2026
42.55%
Market Cap184.30M +60.3%
Revenue (ttm)793.91M +3.7%
Net Income35.05M
EPS0.74
Shares Outn/a
PE Ratio5.26
Forward PEn/a
Dividend0.04 (1.00%)
Ex-Dividend DateJun 5, 2025
Volume500
Average Volume410
Open3.800
Previous Close4.000
Day's Range3.800 - 4.020
52-Week Range2.700 - 4.060
Betan/a
RSI60.16
Earnings DateMar 27, 2026

About FRA:MED

MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, and others. The company also provides services in the areas of ENT and acute outpatient services. It owns clinics, rehabilitation care, nursing care fac... [Read more]

Industry Specialty Outpatient Facilities, Not Elsewhere Classified
Founded 1994
Employees 6,974
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MED
Full Company Profile

Financial Performance

Financial Statements

News

EQS-AFR: MEDICLIN AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

EQS Preliminary announcement financial reports: MEDICLIN AG / Preliminary announcement on the disclosure of financial statements MEDICLIN AG: Preliminary announcement of the publication of quarterly r...

2 months ago - Wallstreet:Online

EQS-AFR: MEDICLIN AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: MEDICLIN AG / Preliminary announcement on the disclosure of financial statements MEDICLIN AG: Preliminary announcement of the publication of financial r...

2 months ago - Wallstreet:Online

MEDICLIN: Thriving Business Growth Exceeds Expectations

MEDICLIN's financial performance in the first nine months of 2025 showcases resilience and growth. With a notable 5.1% increase in sales and a significant rise in operating results, the company has de...

3 months ago - Wallstreet:Online

EQS-News: MEDICLIN on track: business development in line with expectations

EQS-News: MEDICLIN AG / Key word(s): 9 Month figures/Miscellaneous MEDICLIN on track: business development in line with expectations 04.11.2025 / 14:13 CET/CEST The issuer is solely responsible for th...

3 months ago - Wallstreet:Online

MEDICLIN AG: Shareholders Back All AGM Resolutions!

In a landmark virtual gathering, MEDICLIN AG celebrated a record-breaking year at its Annual General Meeting on June 4, 2025. With unanimous support for all resolutions, the company is poised to revol...

8 months ago - Wallstreet:Online

EQS-News: MEDICLIN AG: Annual General Meeting approves all proposed resolutions

EQS-News: MEDICLIN AG / Key word(s): AGM/EGM MEDICLIN AG: Annual General Meeting approves all proposed resolutions 04.06.2025 / 13:27 CET/CEST The issuer is solely responsible for the content of this ...

8 months ago - Wallstreet:Online

MEDICLIN Celebrates a Successful 2024 Financial Year

In 2024, MEDICLIN AG reached unprecedented financial success, with sales hitting EUR 748.8 million and an operating result of EUR 53.5 million, thanks to strategic growth and key acquisitions. Jetzt d...

11 months ago - Wallstreet:Online

EQS-News: MEDICLIN ends successful 2024 financial year

EQS-News: MEDICLIN AG / Key word(s): Annual Report/Miscellaneous MEDICLIN ends successful 2024 financial year 28.03.2025 / 10:24 CET/CEST The issuer is solely responsible for the content of this annou...

11 months ago - Wallstreet:Online